Abrahmsén-Alami S - Search Results

1

Evaluation in pig of an intestinal administration device for oral peptide delivery.

Berg S, Uggla T, Antonsson M, Nunes SF, Englund M, Rosengren L, Fahraj M, Wu X, Govender R, Söderberg M, Janzén D, Van Zuydam N, Hugerth A, Larsson A, Abrahmsén-Alami S, Abrahamsson B, Davies N, Bergström CAS. Berg S, et al. Among authors: abrahmsen alami s. J Control Release. 2023 Jan;353:792-801. doi: 10.1016/j.jconrel.2022.12.011. Epub 2022 Dec 16. J Control Release. 2023. PMID: 36493948

2

A Review of PAT Strategies in Secondary Solid Oral Dosage Manufacturing of Small Molecules.

Laske S, Paudel A, Scheibelhofer O; Author Team. Laske S, et al. J Pharm Sci. 2017 Mar;106(3):667-712. doi: 10.1016/j.xphs.2016.11.011. Epub 2016 Nov 22. J Pharm Sci. 2017. PMID: 28017464 Review.

3

New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide).

Abrahmsén-Alami S, Körner A, Nilsson I, Larsson A. Abrahmsén-Alami S, et al. Int J Pharm. 2007 Sep 5;342(1-2):105-14. doi: 10.1016/j.ijpharm.2007.05.005. Epub 2007 May 13. Int J Pharm. 2007. PMID: 17580107

4

Influence of substitution pattern on solution behavior of hydroxypropyl methylcellulose.

Viridén A, Wittgren B, Andersson T, Abrahmsén-Alami S, Larsson A. Viridén A, et al. Biomacromolecules. 2009 Mar 9;10(3):522-9. doi: 10.1021/bm801140q. Biomacromolecules. 2009. PMID: 19173653

5

The impact of dose and solubility of additives on the release from HPMC matrix tablets--identifying critical conditions.

Tajarobi F, Abrahmsén-Alami S, Hansen M, Larsson A. Tajarobi F, et al. Pharm Res. 2009 Jun;26(6):1496-503. doi: 10.1007/s11095-009-9861-y. Epub 2009 Mar 12. Pharm Res. 2009. PMID: 19280323

6

Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.

Tajarobi F, Abrahmsén-Alami S, Carlsson AS, Larsson A. Tajarobi F, et al. Eur J Pharm Sci. 2009 May 12;37(2):89-97. doi: 10.1016/j.ejps.2009.01.008. Epub 2009 Jan 31. Eur J Pharm Sci. 2009. PMID: 19429415

7

Dissolution rate enhancement of parabens in PEG solid dispersions and its influence on the release from hydrophilic matrix tablets.

Tajarobi F, Abrahmsén-Alami S, Larsson A. Tajarobi F, et al. J Pharm Sci. 2011 Jan;100(1):275-83. doi: 10.1002/jps.22248. Epub 2010 Jun 22. J Pharm Sci. 2011. PMID: 20572053

8

A mechanistic modelling approach to polymer dissolution using magnetic resonance microimaging.

Kaunisto E, Abrahmsen-Alami S, Borgquist P, Larsson A, Nilsson B, Axelsson A. Kaunisto E, et al. J Control Release. 2010 Oct 15;147(2):232-41. doi: 10.1016/j.jconrel.2010.07.102. Epub 2010 Jul 18. J Control Release. 2010. PMID: 20647024

9

The influence of crystallization inhibition of HPMC and HPMCAS on model substance dissolution and release in swellable matrix tablets.

Tajarobi F, Larsson A, Matic H, Abrahmsén-Alami S. Tajarobi F, et al. Eur J Pharm Biopharm. 2011 May;78(1):125-33. doi: 10.1016/j.ejpb.2010.11.020. Epub 2010 Dec 17. Eur J Pharm Biopharm. 2011. PMID: 21168491

10

Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.

Viridén A, Abrahmsén-Alami S, Wittgren B, Larsson A. Viridén A, et al. Eur J Pharm Biopharm. 2011 Aug;78(3):470-9. doi: 10.1016/j.ejpb.2011.02.003. Epub 2011 Feb 18. Eur J Pharm Biopharm. 2011. PMID: 21316446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters